(Q48724548)

15 February 2018

title

Role of MIB1 in predicting survival in patients with glioblastomas. (English)

1 reference

15 February 2018

author name string

Shaye I Moskowitz

series ordinal

1

1 reference

15 February 2018

Tao Jin

series ordinal

2

1 reference

15 February 2018

Richard A Prayson

series ordinal

3

1 reference

15 February 2018

publication date

1 January 2006

1 reference

15 February 2018

Journal of Neuro-Oncology

published in

1 reference

15 February 2018

volume

76

1 reference

15 February 2018

issue

2

1 reference

15 February 2018

page(s)

193-200

1 reference

15 February 2018

https://scigraph.springernature.com/pub.10.1007/s11060-005-5262-1

exact match

0 references

cites work

Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11060-005-5262-1

Impact of genotype and morphology on the prognosis of glioblastoma

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11060-005-5262-1

Pediatric high-grade astrocytomas show chromosomal imbalances distinct from adult cases

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11060-005-5262-1

Prognostic significance of Ki67, p53 and epidermal growth factor receptor immunostaining in human glioblastomas.

21 January 2018

1 reference

12 December 2020

Enhanced radiosensitivity of malignant glioma cells after adenoviral p53 transduction

1 reference

12 December 2020

Survival and functional status after resection of recurrent glioblastoma multiforme.

1 reference

12 December 2020

Value of MIB-1 labelling index (LI) in gliomas and its correlation with other prognostic factors. A clinicopathologic study.

1 reference

12 December 2020

Bromodeoxyuridine labeling index in glioblastoma multiforme: relation to radiation response, age, and survival.

1 reference

12 December 2020

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials.

1 reference

12 December 2020

Role of radiation therapy and radiosurgery in glioblastoma multiforme

1 reference

12 December 2020

Prognostic significance of an apoptotic index and apoptosis/proliferation ratio for patients with high-grade astrocytomas

1 reference

12 December 2020

The influence of sex and the presence of giant cells on postoperative long-term survival in adult patients with supratentorial glioblastoma multiforme

1 reference

12 December 2020

Preoperative systemic treatment: prediction of responsiveness.

1 reference

12 December 2020

Ki67 protein: the immaculate deception?

1 reference

12 December 2020

High expression of DNA topoisomerase IIalpha and Ki-67 antigen is associated with prolonged survival in glioblastoma patients

1 reference

12 December 2020

Diagnostic and prognostic role of Ki67 immunostaining in human astrocytomas using four different antibodies.

1 reference

12 December 2020

The effect of extent of resection on time to tumor progression and survival in patients with glioblastoma multiforme of the cerebral hemisphere.

1 reference

12 December 2020

CD44 expression and tumour cell density correlate with response to tamoxifen/carboplatin chemotherapy in glioblastomas

1 reference

12 December 2020

Pretreatment factors predict overall survival for patients with low-grade glioma: a recursive partitioning analysis

1 reference

12 December 2020

Prognostic significance of endothelial surface score and MIB-1 labeling index in glioblastoma.

1 reference

12 December 2020

Prognostic implication of clinical, radiologic, and pathologic features in patients with anaplastic gliomas.

1 reference

12 December 2020

Long-term survival in patients with glioblastoma multiforme

1 reference

12 December 2020

The prognostic value of tumor markers in patients with glioblastoma multiforme: analysis of 32 patients and review of the literature

1 reference

12 December 2020

Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution.

1 reference

12 December 2020

PCNA and Ki-67 in central nervous system tumors: correlation with the histological type and grade.

1 reference

12 December 2020

Patient age, histologic features, and length of survival in patients with glioblastoma multiforme.

1 reference

12 December 2020

Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis

1 reference

12 December 2020

Grading of diffusely infiltrating astrocytomas by quantitative histopathology, cell proliferation and image cytometric DNA analysis. Comparison of 133 tumours in the context of the WHO 1979 and WHO 1993 grading schemes.

1 reference

12 December 2020

Which glioblastoma multiforme patient will become a long-term survivor? A population-based study.

1 reference

12 December 2020

Ki-67 labeling is correlated with the time to recurrence in primary glioblastomas.

1 reference

12 December 2020

The intrinsic radioresistance of glioblastoma-derived cell lines is associated with a failure of p53 to induce p21(BAX) expression

1 reference

12 December 2020

Brain-tumor cell kinetics correlated with survival

1 reference

12 December 2020

Prognostic significance of annexin VII expression in glioblastomas multiforme in humans

1 reference

12 December 2020

Ki-67 antigen expression as a prognostic factor in primary and recurrent astrocytomas.

1 reference

12 December 2020

Immunohistochemical markers for prognosis of cerebral glioblastomas.

1 reference

12 December 2020

Prognostic value of the expression of tumor suppressor genes p53, p21, p16 and prb, and Ki-67 labelling in high grade astrocytomas treated with radiotherapy.

1 reference

12 December 2020

MIB-1 and DNA topoisomerase II alpha could be helpful for predicting long-term survival of patients with glioblastoma.

1 reference

12 December 2020

Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials

1 reference

12 December 2020

Prognostic significance of Ki-67 proliferation index in supratentorial fibrillary astrocytic neoplasms

1 reference

12 December 2020

Impact of proliferation index on outcome in childhood malignant gliomas: results in a multi-institutional cohort

1 reference

12 December 2020

Analysis of proliferation markers and p53 expression in gliomas of astrocytic origin: relationships and prognostic value.

1 reference

12 December 2020

Prognostic relevance of MAPK expression in glioblastoma multiforme.

1 reference

12 December 2020

Proliferative activity of microvascular cells in glioblastomas does not correlate with time to recurrence.

1 reference

12 December 2020

Ki-67 (clone MIB-1) proliferation index in recurrent glial neoplasms: no prognostic significance

1 reference

12 December 2020

Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project

1 reference

12 December 2020

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

12 December 2020

Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas.

1 reference

12 December 2020

Relationship between Ki-67 labeling index and survival in high-grade glioma patients treated after surgery with tamoxifen.

1 reference

12 December 2020

A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival

1 reference

12 December 2020

10.1007/S11060-005-5262-1

Identifiers

DOI

1 reference

15 February 2018

1 reference

15 February 2018